Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of single oral doses of ID110521156 in healthy adult subjects. This is the first clinical study of ID110521156.
Epistemonikos ID: 923dcf93f98fc5bada51ba44b0babc46c32be038
First added on: May 15, 2024